R Balena Selected Research

taspoglutide

3/2013	Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6).
1/2013	Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial.
5/2010	Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study.
11/2009	Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Balena Research Topics

Disease

5	Type 2 Diabetes Mellitus (MODY) 06/2013 - 11/2009
3	Postmenopausal Osteoporosis 05/2000 - 01/2000
2	Weight Loss (Weight Reduction) 06/2013 - 03/2013
2	Weight Gain 06/2013 - 03/2013
1	Body Weight (Weight, Body) 03/2013
1	Injection Site Reaction 03/2013

Drug/Important Bio-Agent (IBA)

4	taspoglutideIBA 03/2013 - 11/2009
4	Metformin (Glucophage)FDA LinkGeneric 03/2013 - 11/2009
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2013 - 11/2009
3	Etidronic Acid (HEDP)FDA LinkGeneric 05/2000 - 01/2000
1	Insulin (Novolin)FDA Link 06/2013
1	Pioglitazone (Actos)FDA Link 03/2013
1	Insulin Glargine (Lantus)FDA Link 01/2013

Therapy/Procedure

4	Therapeutics 06/2013 - 05/2000
1	Subcutaneous Injections 11/2009
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 05/2000